Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

XSpray Pharma AB (publ)

Closing information (x1000 NOK)

Closing information 2023/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 684 Less Arrow 4 More Arrow 6
Earnings before taxes -182,026 More Arrow -94,302 More Arrow -54,905
EBITDA -184,102 More Arrow -95,526 More Arrow -56,002
Total assets 775,236 Less Arrow 607,469 More Arrow 634,116
Current assets 220,654 More Arrow 275,076 More Arrow 346,772
Current liabilities 40,423 Less Arrow 29,224 Less Arrow 20,761
Equity capital 702,449 Less Arrow 577,090 More Arrow 610,319
- share capital 31,661 Less Arrow 20,168 Less Arrow 19,792
Employees (average) 26 Less Arrow 22 Less Arrow 20

Financial ratios

Fiscal year 2023/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 90.6% More Arrow 95.0% More Arrow 96.2%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -23.4% More Arrow -15.5% More Arrow -8.7%
Current ratio 545.9% More Arrow 941.3% More Arrow 1670.3%
Return on equity (ROE) -25.9% More Arrow -16.3% More Arrow -9.0%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 4 Less Arrow 2 More Arrow 3
Chg. No. of employees % 18% Less Arrow 10% More Arrow 18%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.